HARBOUR INVESTMENTS, INC. - BIOHAVEN PHARMACTL HLDG CO L ownership

Back to all holdings Add to watchlist

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.

Filings

EDGAR links

External links

Quarter-by-quarter ownership

HARBOUR INVESTMENTS, INC. ownership history of BIOHAVEN PHARMACTL HLDG CO L
	Value		Shares		Weighting
Q3 2022	$7,000	0.0%	45	0.0%	0.00%	–
Q2 2022	$7,000	-30.0%	45	-38.4%	0.00%	-100.0%
Q4 2021	$10,000	-98.7%	73	-99.1%	0.00%	-96.0%
Q2 2021	$777,000	+41.5%	8,004	-0.3%	0.02%	+25.0%
Q1 2021	$549,000	–	8,028	–	0.02%	–
Download

Other shareholders

BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2021
Name	Shares	Value	Weighting ↓
Knoll Capital Management, LLC	450,422	$6,251,857	14.11%
Liontrust Investment Partners LLP	134,659	$7,478,961	0.13%
Birchview Capital, LP	7,365	$102	0.07%
FNY Investment Advisers, LLC	250	$3	0.00%
FNY Investment Advisers, LLC	18	$0	0.00%
FNY Investment Advisers, LLC	56	$0	0.00%
McElhenny Sheffield Capital Management, LLC	31	$430	0.00%
Blue Trust, Inc.	65	$10	0.00%
IFP Advisors, Inc	1	$1	0.00%

View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders